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Abstract
Recent studies showed that endocytosis is enhanced in
neurons exposed to an excitototoxic stimulus. We here con-
firm and analyze this new phenomenon using dissociated
cortical neuronal cultures. NMDA-induced uptake (FITC-dex-
tran or FITC or horseradish peroxidase) occurs in these cul-
tures and is due to endocytosis, not to cell entry through
damaged membranes; it requires an excitotoxic dose of
NMDA and is dependent on extracellular calcium, but occurs
early, while the neuron is still intact and viable. It involves two
components, NMDA-induced and constitutive, with different
characteristics. Neither component involves specific binding of
the endocytosed molecules to a saturable receptor. Strikingly,
molecules internalized by the NMDA-induced component are
targeted to neuronal nuclei. This component, but not the
constitutive one, is blocked by a c-Jun N-terminal protein
kinase inhibitor. In conclusion, an excitotoxic dose of NMDA
triggers c-Jun N-terminal protein kinase-dependent endocy-
tosis in cortical neuronal cultures, providing an in vitro model
of the excitotoxicity-induced endocytosis reported in intact
tissues.
Keywords: c-Jun N-terminal kinase, dextran, D-JNKI1, neu-
rons, NMDA, primary culture.
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Endocytosis is the main mechanism by which cells internal-
ize material from their extracellular environment, and has the
additional roles of down-regulating the membrane expression
of certain molecules, notably receptors, and adjusting the
total amount of plasma membrane following exocytosis.
From the initial membrane-derived vesicles, the endocytosed
molecules can be recycled to the plasma membrane or
transported to various destinations including lysosomes
(Conner and Schmid 2003). It plays a crucial role in many
cellular events such as homeostasis, signal transduction,
neurotransmission, and the immune response (Sorkin and
von Zastrow 2002; Conner and Schmid 2003). Many forms
of endocytosis, including receptor-mediated endocytosis and
compensatory endocytosis following exocytosis, depend on
the formation of clathrin-coated vesicles (Jarousse and Kelly
2001). Other forms are largely independent of clathrin, but
are mediated by cholesterol-rich membrane domains such as
lipid rafts and caveolae, or by still other routes that are poorly
understood (Kirkham and Parton 2005).
The present study focuses on endocytosis in the context of
neuronal excitotoxicity. In most cases excitotoxic cell death
results from calcium overload, the activation of calcium-
dependent enzymes, and mitochondrial dysfunction (Arun-
dine and Tymianski 2003). Excitotoxicity is involved in
many neurological conditions, including cerebral ischemia
and traumatic brain injury, and appears to play an important
role in most neurodegenerative diseases (Doble 1999; Aarts
et al. 2003). Endocytosis is enhanced in at least two cases of
excitotoxicity: retinal amacrine cells of chick embryos
following an intraocular injection of kainate (KA) (Borsello
et al. 2003a), and pyramidal neurons in organotypic
hippocampal cultures exposed to a toxic dose of N-methyl
D-aspartate (NMDA) (Borsello et al. 2003c).
The pathways mediating excitotoxic cell death are com-
plex, but in many cases involve the activation of mitogen-
activated protein kinases (Borsello et al. 2003b; Waxman
and Lynch 2005) which are also involved in mediating
certain forms of endocytosis (Cavalli et al. 2001; Borsello
et al. 2003c; Pelkmans et al. 2005). D-JNKI1, a cell-pene-
trating and protease-resistant peptide selectively inhibiting
the interaction of c-Jun N-terminal protein kinase (JNK) with
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many of its targets was previously shown to block NMDA-
induced endocytosis of horseradish peroxidase (HRP) by
pyramidal neurons in organotypic hippocampal slices (Bor-
sello et al. 2003c) as well as protecting the neurons from
death.
To examine the mechanisms inducing excitotoxicity-
associated endocytosis, and to clarify its involvement in the
mediation of neuronal death, we have developed an in vitro
model relying on the NMDA-induced uptake of ﬂuorescein
isothiocyanate (FITC)-labeled dextran by dissociated cortical
neurons. In the present paper we conﬁrm that the uptake is by
endocytosis rather than leakage through damaged mem-
branes, and describe a method for quantifying it. Using this
method, we characterize the phenomenon, showing that the
neurons undergo both constitutive endocytosis and NMDA-
induced endocytosis. These two types of endocytosis are
distinct in that the NMDA-induced component is sensitive to
the size of the FITC-labeled dextran and dependent on the
c-Jun N-terminal kinase pathway, whereas the constitutive
component is independent of both.
Materials and methods
Chemicals
N-methyl D-aspartate, free FITC, FITC-dextrans, and HRP were
obtained from Sigma-Aldrich Co., (St. Louis, MO, USA). Alexa-
Fluor488-dextran was obtained from Invitrogen (Carlsbad, CA,
USA). Glutamate (GLU) and (5S,10R)-(-)-5-methyl-10, 11-dihydro-
5H-dibenzo[a,d]cyclohepten-5,10-imine hydrogen maleate (MK-
801) were from Tocris, kainic acid (kainate) from Opika.
Primary cell culture
Primary neuronal cultures of cerebral cortex were prepared from
2-day-old Sprague–Dawley rats. Brieﬂy, small pieces of cortex were
dissected and incubated with 200 units of papaı¨n for 30 min at
34C. For biochemical analysis, dissociated cells were plated at
densities of approximately 0.6 · 106 cells/dish on poly-D-lysine pre-
coated 35 mm dishes in B27/Neurobasal (Invitrogen) supplemented
with 0.5 mmol/L glutamine and 100 lg/mL penicillin–streptomy-
cin. Cells were maintained at 37C with a 5% CO2-containing
atmosphere for 12 days, with half of the media changed every 3–
4 days. Morphological studies were done using 12 mm pre-coated
coverslips plated at a density of approximately 15 · 105 cells/dish.
Assay for FITC uptake and quantification of cell death
Cells were incubated in the presence or absence of various doses of
NMDA (30, 60, or 100 lmol/L) for 1 or 6 h, and were exposed for an
equal time (1 or 6 h) to FITC-dextran (4.4 kDa, 0.5 mg/mL) or free
FITC (1.25 lg/mL). Dishes were then placed on ice and rinsed ﬁve
times with cold phosphate-buffered saline (PBS)-MgCl2 for 5 min.
Cells were lysed using 200 lL of lysis buffer (20 mmol/L HEPES,
pH 7.4; 10 mmol/L NaCl; 3 mmol/L MgCl2; 2.5 mmol/L EGTA;
0.1 mmol/L dithiothreitol; 50 mmol/L NaF; 1 mmol/L Na3VO4; and
1% Nonidet-P40) for 10 min on ice and were then harvested. Cells
from three dishes were pooled together and centrifuged in lysis buffer
at 4C for 10 min at 335 g to remove cellular debris. The
ﬂuorescence of the supernatant was measured at excitation wave-
length 494 nm and emission 518 nm. Three dishes were pooled for
each measurement and each measurement was repeated in at least
three different experiments. Measurements were normalized with
respect to the non-NMDA control mean value for each set of
experiments.
Cell death was assayed by measurement of lactate dehydrogenase
(LDH) released in the medium using the Cytotox 96 non-radioactive
cytotoxicity assay kit (Promega, Madison, WI, USA). Absorbance
measurements (representing LDH concentration) were converted
into percentage of neuronal death values by dividing by the average
absorbance for total LDH (from medium plus lysed neurons),
measured in different dishes but from same culture.
Propidium iodide (PI) is a polar compound which only enters cells
with damaged cell membranes. It binds to nucleic acids and becomes
brightly red ﬂuorescent. The dye is said to be non-toxic to neurons and
is widely used as a positive indicator of neuronal damage and cell
death (Noraberg et al. 1999). For morphological studies, cells were
exposed to 5 lg/mL PI (Sigma) in PBS–MgCl2 for 5 min on ice and
then washed three more times with cold PBS–MgCl2.
Tetramethylbenzidine assay for peroxidase uptake
The uptake of HRP was measured in experiments similar to those
for monitoring FITC-dextran uptake, but performed in the presence
of 0.5 mg/mL HRP. Cellular HRP activity was measured using
3,3¢,5,5¢-tetramethylbenzidine (TMB) as HRP substrate. Brieﬂy
TMB was dissolved in phosphate citrate buffer containing H202 at
0.6%. 100 lL of sample was incubated with TMB substrate for
3 min. The reaction was stopped by adding 0.5 mol/L H2SO4, and
the absorbance of the reaction product was read at 405 nm.
Measurements were normalized with respect to the non-NMDA
control value, which was arbitrarily set to 100%.
Peptidic JNK inhibitor
The JNK-inhibitory peptide D-JNKI1 is a retro-inverso analog
(D-amino acids in reversed sequence) of L-JNKI1, which contains a
20-aa sequence of the JNK binding domain of Islet-Brain-1/JNK-
interacting protein-1 scaffold protein, linked to the 10-aa intracel-
lular delivery vector trans-activator of transcription (TAT)48–57 from
the HIV TAT protein (Borsello et al. 2003b). The use of a retro-
inverso analog provides resistance to degradation by proteases while
conserving, at least approximately, the original tertiary structure.
D-JNKI1 does not inhibit the activity of c-Jun N-terminal kinase
(JNK), but blocks its interaction with those of its targets that contain
a JNK-binding domain (Bonny et al. 2005). In all experiments
2 lmol/L D-JNKI1 was added 1 h before NMDA treatment, which
gives strong protection against excitotoxicity (Borsello et al.
2003b).
Time-lapse microscopy
Neurons were grown in a time-lapse chamber for 12 days and then
exposed to 0.5 mg/mL AlexaFluor488-dextran (AF488-dextran) for
25 min in presence or absence of 100 lmol/L NMDA. Cells were
then washed two times with complete medium. To permit high-
resolution imaging with an inverted microscope, we plated neurons
onto HCl-cleaned, poly-D-lysine-coated glass coverslips (Carolina
Biologicals, Burlington, NC, USA) that had previously been
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attached using hot vaseline/wax (50 : 50) to 35 mm plastic culture
dishes (Corning, Lowell, MA, USA) in which holes 15 mm in
diameter had been machine drilled (Lebrand et al. 2004). After
12 days in culture, the lids were removed and the dishes placed on
the stage of a Nikon TE300 microscope. Temperature was
maintained at 37C and CO2 was maintained at 5% using a
microscope incubator system (Solent Scientiﬁc Limited, Segens-
worth, UK). Selected neurons were imaged with a 20 · /0.95NA
planar Apo objective at 20 min intervals. Images were captured with
an Orca-ER cooled CCD camera (Hamamatsu, Japan). All periph-
erals were controlled with Metamorph software (Universal Imaging,
Downington, PA, USA). Images were processed in Adobe Photo-
shop or Metamorph.
Immunofluorescent imaging
Cells were washed three times with PBS–MgCl2 on ice and
mounted in Fluorsave mounting medium (Calbiochem, San Diego,
CA, USA). Several artifactual localizations of various compounds
after different ﬁxation procedures have already been observed
(Richard et al. 2003), depending on the size or on the charge
composition of the product. Cells were therefore not ﬁxed and
were examined in the 2 days following experiment. Confocal
imaging was performed on a LSM 510 Meta confocal microscope
(Carl Zeiss, Thornwood, NY, USA). Images were processed with
LSM 510 software and mounted using Adobe Photoshop.
Statistical analysis
Data were analyzed statistically by one-way ANOVA followed by
Students’ t-test (one-tailed, two-sample, and unequal variance).
Results
NMDA-enhanced uptake of FITC-dextran is
concentration- and time-dependent
Increasing doses of NMDA (30 lmol/L, 60 lmol/L, or
100 lmol/L) were applied for either 1 or 6 h on the cultured
neurons. Control neurons were not exposed to NMDA,
permitting the quantiﬁcation of constitutive uptake. The
results in Fig. 1a show that the constitutive uptake of 4,
4-kDa FITC-dextran increased with the duration of incuba-
tion and that NMDA stimulation enhanced the uptake. The
induced increase depended on both the exposure time (111%
increase after 1 h of 100 lmol/L NMDA and 235% after 6 h
of NMDA) and the NMDA concentration: the slight increase
induced by 30 lmol/L NMDA was not signiﬁcant after 1 or
6 h of NMDA exposure, whereas 60 and 100 lmol/L
NMDA induced signiﬁcant increases at both observed times.
A standard dose of 100 lmol/L NMDA was chosen for all
subsequent experiments as it induced the greatest enhance-
ment in endocytosis.
The effect of NMDA on cell death was assessed by
measuring LDH release in the medium (Fig. 1b). One hour
of 100 lmol/L NMDA stimulation induced little if any
neuronal death (5.8%) whereas 6 h of NMDA exposure at
the same concentration evoked a very consistent cell death
(33.6%). After 1 h of 30 lmol/L NMDA, even though there
was almost no cell death (2.1%), a slight increase (x1.5) in
FITC-dextran endocytosis occurred, but not signiﬁcant. The
fact that the threshold NMDA concentrations for induced
endocytosis and for cell death were similar suggests a link
between NMDA-induced endocytosis and cell death that
remains to be elucidated.
The NMDA-evoked cellular FITC-dextran uptake is
energy dependent
To evaluate whether the dextran uptake was due to a
physiological temperature sensitive process such as endocy-
tosis, we tested if incubation on ice blocked it. Cells were
pre-incubated on ice for 30 min and were then exposed to
100 lmol/L NMDA for 1 h, still on ice. FITC-dextran
incorporation was greatly decreased by the temperature
(b)
(a)
Fig. 1 Dose- and time-dependent effects of N-methyl D-aspartate
(NMDA) on fluorescein isothiocyanate (FITC)-dextran uptake and cell
death. (a) Uptake of 4.4-kDa FITC-dextran after either 1 or 6 h of
NMDA exposure (n = 3, with three dishes pooled for each measure).
Results have been normalized with respect to the 6 h control. ANOVA
showed significant differences between the 1 h groups (p = 0.033)
and between the 6 h groups (p = 0.013). Comparisons with the cor-
responding control: *p < 0.05, **p < 0.01 (t-test). (b) Cell death in the
same cultures, assessed from lactate dehydrogenase (LDH) release in
the medium. Results are expressed as the difference of LDH after and
before the experiment and have been normalized with respect to the
control (without NMDA) value (n = 3). ANOVA showed significant dif-
ferences between the 1 h groups (p = 0.0018) and between the 6 h
groups (p = 0.0002). Comparisons with the corresponding control:
**p < 0.01 (t-test). Error bars represent SEM.
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reduction, thus indicating a physiological, energy-dependent
phenomenon, presumably endocytosis. The residual uptake,
occurring even at 4C was insensitive to NMDA (Fig. 2a).
One hour exposure to 100 lmol/L NMDA at 37C was only
moderately toxic (0.5% cell death), and the incubation on ice
protected totally against this; moreover, the 90 min incuba-
tion on ice was not itself toxic (Fig. 2b) although the cells
could not resist ice treatment for several hours (not shown).
Thus, both the constitutive and the NMDA-induced compo-
nents of the FITC-dextran uptake were temperature depend-
ent, indicative of a step requiring energy.
NMDA-induced endocytosis is size dependent
The size dependence of the endocytosis was evaluated using
the small (4.4 kDa) FITC-dextran and a much larger one
(150 kDa). As shown in Fig. 3, although the levels of
constitutive endocytosis were comparable with the small and
large dextrans, the NMDA-induced enhancement was min-
imal with the larger one, being weak at 1 h and non-existent
at 6 h. This difference in size dependence suggests that the
constitutive endocytosis is mainly due to macropinocytosis
whereas the NMDA-induced component is mainly due to
other mechanisms (see Discussion).
Neither component of the endocytosis is mediated by a
receptor for dextran
To test if the endocytosis was receptor-mediated, we
performed competition experiments using a 10 kDa non-
ﬂuorescent dextran (Figs 4a and b).The cells were incuba-
ted with unlabeled dextran at a concentration of 0.5 or
5 mg/mL for 10 min before addition of FITC-dextran (at
0.5 mg/mL). Neither in the presence nor in the absence of
NMDA was FITC-dextran uptake signiﬁcantly reduced by
either dose of unlabeled dextran. These results indicate that
neither the constitutive nor the NMDA-induced component
of dextran uptake is receptor-mediated, at least not for
dextran as ligand.
We then repeated the experiment of FITC-dextran
uptake using free FITC (Fig. 4c). Uptake of free FITC
was also enhanced in the presence of NMDA, raising the
possibility that FITC might have served as a ligand for
(a) 
(b) 
Fig. 2 Effect of lowering the temperature on N-methyl D-aspartate
(NMDA)-induced endocytosis. Neurons were incubated on ice for
30 min before NMDA-administration and throughout the 1 h exposure,
or for 90 min (control), or were maintained at 22C (RT). (a) Uptake of
4.4-kDa fluorescein isothiocyanate (FITC)-dextran. ANOVA showed a
significant difference between the four groups (p < 0.0001). Compar-
isons with RT groups: *p < 0.05 (t-test); effect of NMDA in RT group:
#p = 0.016 (t-test). (b) Lactate dehydrogenase (LDH) release in the
same cultures. n = 3, ANOVA showed a significant difference between
the four groups (p < 0.0001). Effect of NMDA in RT group: #p = 10)5
(t-test). Error bars represent SEM.
(a) 
(b) 
Fig. 3 (a) Size-dependence of fluorescein isothiocyanate (FITC)-
dextran uptake following 100 lmol/L N-methyl D-aspartate (NMDA).
Neurons were incubated with 0.5 mg/mL of two different sizes of FITC-
dextran [4.4-kDa, 4.4 kDa FITC-dextran (FD4) or 150-kDa, 150 kDa
FITC-dextran (FD150)] for either 1 or 6 h. Relative fluorescence be-
tween the two was measured after each experiment and normalized.
ANOVA showed significant differences between the four 1 h groups
(p = 0.046) and between the four 6 h groups (p = 0.014). Compari-
sons between corresponding NMDA and non-NMDA conditions:
*p < 0.05, #p < 0.01. (b) Lactate dehydrogenase (LDH) release, in the
same cultures. The values have been normalized as in Fig. 1b. In the
four 6 h groups, ANOVA indicated significant differences (p = 0.0001).
Comparisons by t-test between corresponding NMDA and non-NMDA
conditions: #p < 0.01; between FD4 and FD150 at 6 h: *p < 0.01.
Error bars represent SEM.
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receptor-mediated. However, further experiments indicated
that the uptake of HRP was also enhanced by 6 h of
100 lmol/L NMDA exposure (Fig. 4d). In view of the
diversity of ligands endocytosed, and the lack of compe-
tition with unlabeled dextran, it would seem that the
NMDA-induced endocytosis is not dependent on a speciﬁc
receptor. The LDH assay conﬁrmed that neither free FITC
nor HRP were toxic or affected by the NMDA toxicity
(results not shown).
The enhanced endocytosis of FITC-dextran depends
mainly on NMDA-receptors
N-Methyl D-aspartate, KA, or GLU (100 lmol/L in each
case) were applied in the presence or absence of the non-
competitive NMDA antagonist MK-801 (40 lmol/L). The
results in Fig. 5a show that each of these agonists was able to
induce an enhanced uptake of 4.4 kDa FITC-dextran (FD4).
NMDA-induced endocytosis was totally blocked by MK-801
(96% reduction of the induced component, p £ 10)4) and
GLU-induced endocytosis was likewise strongly inhibited
(by 85%, p = 0.067). KA-induced endocytosis was weaker,
and was partially blocked by MK-801 (by 32%, p £ 0.05).
The strong inhibition of GLU-induced endocytosis by
MK-801 suggests a predominant role of NMDA receptors
in this phenomenon. MK-801 almost totally protected against
the toxicity of NMDA and GLU, as measured by LDH
release in the medium, but only slightly reduced (by 17%)
the toxic effect of KA (Fig. 5b).
The NMDA-induced endocytosis is Ca2+-dependent
The role of extracellular Ca2+ was investigated by pre-
incubating the cells with the calcium chelator EGTA
(5 mmol/L). This strongly reduced the NMDA-induced
endocytosis of FD4 (Fig. 5c, FD4 uptake reduced by 82%,
p £ 0.001), and slightly reduced also the constitutive com-
ponent of the endocytosis (by 34.6%, p £ 0.05). NMDA
induced toxicity was abolished by the EGTA (Fig. 5d).
Depolarization-induced endocytosis occurred late and
involved NMDA receptors
Neurons were exposed to 100 lmol/L NMDA or 90 mmol/L
KCl for either 6 or 12 h. In the latter case, FITC-dextran was
added for the last 6 h only to exclude a degradation of this
molecule as compared with the 6 h experiment. The level of
NMDA-induced endocytosis was comparable after 6 or 12 h
(Fig. 6a), whereas high potassium induced an enhanced
uptake only after 12 h of incubation. Moreover, the latter
effect was almost totally abolished by MK-801, indicating
that it required the activation of NMDA receptors. NMDA-
induced toxicity increased over time (Fig. 6b), as did KCl-
induced toxicity. MK-801 had no effect on the KCl toxicity
after 6 h of exposure, but did protect after 12 h (by 31.5%,
p £ 0.05). Thus, the effects of MK-801 on depolarization-
induced endocytosis and cell death occurred late, between 6
and 12 h, presumably because of the accumulation of GLU
in the medium following its depolarization-induced release.
NMDA-induced nuclear accumulation of FITC-dextran
Cortical neurons showed marked cellular uptake when
exposed to FITC-dextran for 1 h or more. In control
condition (without NMDA), most neurons displayed a faint
punctate ﬂuorescence pattern, the FITC labeling appeared to
be restricted to the cytosol and to be in cytoplasmic
organelles, presumably endosomes and perhaps lysosomes
(a)
(b)
(c) (d)
Fig. 4 Competition experiments with unlabeled dextran. (a) Uptake
of 4.4-kDa fluorescein isothiocyanate (FITC)-dextran (FD4). Neurons
were pre-incubated with 0.5- or 5-mg/mL 10-kDa unlabeled dextran
(D10) for 10 min before exposure to 4.4-kDa FITC-dextran. ANOVA
indicated significant differences between the six groups (p = 0.0007).
Comparisons by t-test between corresponding N-methyl D-aspartate
(NMDA) and non-NMDA conditions: *p < 0.05, **p < 0.01. (b) Lactate
dehydrogenase (LDH) release, in the same cultures. The values have
been normalized as in Fig. 1b, n = 4. ANOVA indicated significant dif-
ferences between the six groups (p = 0.0001). Comparisons by t-test
between corresponding NMDA and non-NMDA conditions: **p < 0.01.
(c and d) Uptake of two other ligands following NMDA exposure.
Neurons were incubated with free FITC (1.25 lg/mL) or horseradish
peroxidase (HRP, 0.5 mg/mL) for 6 h in presence or not of 100 lmol/L
NMDA. #p < 0.01 compared with non-NMDA control, t-test. Error bars
represent SEM.
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(Fig. 7a). No cell death was detected by PI staining. Under
100 lmol/L NMDA treatment, FITC labeling was enhanced
in the cytoplasm of neurons, but still more strikingly was
very strong in neuronal nuclei (Fig. 7b). FITC staining of the
nucleus was observed in 15.4% of cells after 1 h of NMDA
and remained stable at 6 h of NMDA (12.7% of cells)
(Fig 7c). Strikingly, none of the cells that displayed an
enhanced ﬂuorescence uptake were positive for PI staining,
suggesting that the endocytic cells were not (yet) dying, and
that dying neurons had ceased endocytosis (Fig. 7d).
Relationship between FITC-dextran endocytosis and cell
death
As the neurons with strong nuclear FITC-dextran labeling in
response to brief (1 or 6 h, Fig. 7c ) NMDA exposure were
unlabeled with PI, the question arises whether they die. We
therefore tested the effects of longer exposure. Strikingly,
after 24 h NMDA exposure, these neurons were no longer
visible (Fig. 7, panel g1). At this time-point, the cytoplasmic
(a)
(b)
(c) (d)
Fig. 5 Effects of different glutamate (GLU) agonists and of calcium
on endocytosis and cell death. (a) Uptake of 4.4-kDa fluorescein
isothiocyanate (FITC)-dextran after 6 h of either 100 lmol/L N-methyl
D-aspartate (NMDA), 100 lmol/L kainate (KA), or 100 lmol/L GLU in
the presence or absence of 40 lmol/L (5S,10R)-(-)-5-methyl-10,
11-dihydro-5H-dibenzo[a,d]cyclohepten-5,10-imine hydrogen maleate
(MK-801) (n = 3). ANOVA showed highly significant differences between
the eight groups (p = 0.0001). t-tests: *p £ 10)4 in comparison with the
non-agonist control without MK-801; #p £ 0.05 in comparison with the
corresponding agonist-stimulated condition without MK-801. (b) Cell
death in the same cultures, assessed from lactate dehydrogenase
(LDH) release in the medium. ANOVA showed significant differences
between the eight groups (p £ 0.0001). t-tests: p £ 0.001 in compar-
ison with control (and without MK-801): *p £ 0.001 (t-test), #p £ 0.001
in comparison with the corresponding condition without MK-801. (c)
Effect of the calcium chelator EGTA on 4.4-kDa FITC-dextran uptake
(n = 3). 5 mmol/L EGTA was added to the medium 20 min before
NMDA exposure. ANOVA showed highly significant differences between
the four groups (p = 0.0001). t-tests: *p £ 0.05 in comparison with
control without NMDA; #p £ 0.001 in comparison with NMDA-treated
condition without EGTA. (d) Cell death measured in the same cultures.
ANOVA showed significant differences between the four groups
(p = 0.0002). t-tests: *p £ 0.01 in comparison with control; #p £ 0.05 in
comparison with control conditions with or without NMDA-treatment.
Error bars represent SEM.
(a)
(b)
Fig. 6 Effects ofN-methyl D-aspartate (NMDA) and of high potassium
on endocytosis and cell death. (a) Uptake of 4.4-kDa fluorescein isoth-
iocyanate (FITC)-dextran after 6 or 12 h of NMDA (100 lmol/L) or KCl
(90 mmol/L) incubation. Neurons were pre-incubated for 10 min with
40 lmol/L (5S,10R)-(-)-5-methyl-10,11-dihydro-5H-dibenzo[a,d]cyclo-
hepten-5,10-imine hydrogen maleate (MK-801) before KCl addition to
the medium. FITC-dextran (0.5 mg/mL) was present in the medium for
6 h in both cases (for the last 6 h of incubation in the 12 h experiment).
ANOVA showed highly significant differences between the eight groups
(p £ 0.0001). t-tests: *p £ 0.01 in comparison with the corresponding
control; #p £ 0.05 in comparison with the 12 h KCl-treated condition
without MK-801. (b) Cell death in the same cultures assessed from
lactate dehydrogenase (LDH) released in the medium at the end of
experiment. ANOVA showed highly significant differences between the
eight groups (p £ 0.0001). t-tests: *p £ 0.01 in comparison with the
corresponding control; #p £ 0.05 in comparison with the 12 h
KCl-treated condition without MK-801 or with the corresponding control.
Error bars represent SEM.
794 A. Vaslin et al.
Journal Compilation  2007 International Society for Neurochemistry, J. Neurochem. (2007) 102, 789–800
 2007 The Authors
FITC-dextran labeling was much stronger than after 6 h of
incubation and was comparable in the control and NMDA-
treated condition (Fig. 7, panels f1 and g1), whereas after 6 h,
the control labeling was still weak (panel d1) and some
neurons exposed to NMDA showed a strong FITC-dextran
nuclear accumulation (panel e1, blue arrowhead). In control
conditions no or very rare neurons were labeled with PI
(panels d2 and f2), whereas many were labeled following
NMDA exposure, and their number increased between 6 and
24 h (panels e2 and g2). FITC-labeled nuclei did not contain
PI after 6 or 24 h NMDA (panels e3 and g3), but after 24 h
NMDA, many cells unlabeled with FITC or labeled only in
their cytoplasm contained nuclear PI (panel g3, yellow
arrowhead).
Time-lapse experiments were performed to follow the fate
of the neurons presenting a strong nuclear accumulation of
dextran. AF488-dextran was used in these experiments
because of its higher photostability as compared with
FITC-dextran. Neurons displaying a nuclear accumulation
of AF488-dextran appeared within 30 min. after NMDA
exposure (Fig. 8), whereas control neurons displayed a
punctate labeling in the cytoplasm. In the control condition,
the level of ﬂuorescence was comparable over 10:30 hours of
experiment, indicating that the ﬂuorophore did not bleach
over this period of time and cells were still intact after
10:30 hours as shown by membrane integrity (yellow
arrowhead). In the presence of NMDA, AF488-dextran
labeling rapidly disappeared after 7:30 hours of incubation
(a) (c)(a′)
(b) (b′)
(d1) (d2) (d3)
(e1) (e2) (e3)
(f1) (f2) (f3)
(g1) (g2) (g3)
Fig. 7 Labeling with 4.4-kDa fluorescein
isothiocyanate (FITC)-dextran (FD4) and
propidium iodide (PI) after 1, 6, or 24 h
exposure to N-methyl D-aspartate (NMDA),
visualized by confocal microscopy. (a) Non-
NMDA control condition after 1 h FITC-
dextran exposure. (b) Effect of 1 h
100 lmol/L NMDA exposure on the FITC-
dextran uptake. (a¢ and b¢) Combined
fluorescence and differential interference
contrast (DIC) imaging. Scale bar = 50 lm.
Arrowheads indicate cells enlarged in
insets. (c) Percentage of cells showing
FITC labeling in the nucleus after 1 or 6 h
exposure to NMDA and 4.4-kDa FITC-dex-
tran, and percentage of PI labeled cells.
Similar results were obtained with 6 h
exposure to NMDA and FITC-dextran.
Results are expressed as percentage of
total cells as visualized by Dapi staining.
**p < 10)6 compared with non-NMDA con-
trol; *p < 0.007 compared with non-NMDA
control (t-tests). (d) FITC-dextran exposure
in control conditions for 6 h. (e) Effect of
100 lmol/L NMDA exposure for 6 h on
FITC-dextran uptake (e1) and cell death
(e2); e3 shows combined fluorescence. Blue
arrowhead shows a cell labeled with FD4 in
the nucleus, but not with PI. (f) Neurons
after 24 h of FITC-dextran exposure in
control conditions. (g) Effect of 100 lmol/L
NMDA exposure for 24 h on FITC-dextran
uptake (g1) and cell death (g2); g3 shows
combined fluorescence. Yellow arrowhead
shows a cell labeled with both FD4
(in cytoplasm) and PI. Scale bar, 20 lmol/L.
Error bars represent SEM.
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and membrane integrity was impaired at the same time-point
(red arrowheads).
JNK-dependence of the NMDA-induced component of
endocytosis
We have tested the effects of D-JNKI1, a speciﬁc JNK
inhibitory peptide. It totally blocked the NMDA-induced
component of dextran endocytosis but had no effect on the
constitutive component (Fig. 9b). By confocal microscopy,
NMDA-exposed neurons pre-treated with D-JNKI1 (Fig. 9a)
showed a distribution and intensity of FITC-labeling similar
to that of the control without NMDA (Fig. 7a).
D-JNKI1 also almost totally inhibited the cell death
induced by NMDA exposure, as shown by a complete loss
of PI staining after 1 h (Fig. 9a) but also after 6 h (not
shown) and a strong reduction in LDH release (85%
reduction, Fig. 9c).
Discussion
The motivation for performing the present experiments was
the observation of strongly enhanced endocytosis in retinal
amacrine cells of chick embryos following intraocular
injections of excitotoxic or near-excitotoxic doses of KA
(Borsello et al. 2003a), and in organotypic hippocampal
cultures following excitotoxic doses of NMDA (Borsello
et al. 2003c). As a prelude to subsequent analysis of the
signaling mechanisms underlying this phenomenon, we here
establish nine main conclusions.
The NMDA-induced uptake of FITC-dextran (or free
FITC or HRP) is by endocytosis
The fact that incubation of cells on ice eliminated the
NMDA-induced FITC-dextran uptake as well as much of the
constitutive component indicates that both components were
due largely or entirely to endocytosis. Moreover, the
alternative possibility of a passive entry of FITC-dextran
following a membrane leakage in damaged neurons is
excluded by the ﬁnding that the cells positive for FITC-
dextran were negative for PI, and vice versa. This ﬁts in with
the published ultrastructural observation that the HRP taken
into retinal amacrine cells following an intraocular injection
of KA in chick embryos is located primarily in endosome-
like organelles (Borsello et al. 2003a). Moreover, our
ongoing experiments with pharmacological blockers of
endocytosis conﬁrm that both components are largely due
to endocytosis.
Validity of the fluorescent assay
The above arguments for endocytosis conﬁrm also the
validity of the ﬂuorescent assay. Conceivably, the assay
could have been contaminated by the (perhaps transient)
adherence of FITC-dextran to cell membranes. We attempted
to eliminate these artifacts by multiple washing before
(a) 
(b) 
(c) 
(d) 
Fig. 8 Labeling with AlexaFluor 488
(AF488)-dextran over time. Shown are
images of control or N-methyl D-aspartate
(NMDA)-treated cells at 30 min, 4:30, 7:30,
7:50, and 10:30 hours after NMDA expo-
sure. (a) Control condition, brightfield. Red
arrowheads indicate cell membrane.
(b) Control condition, fluorescence using
fluorescein isothiocyanate (FITC) filters.
(c) NMDA-treated condition, brightfield.
(d) NMDA treated-condition, fluorescence
for FITC. Scale bar = 20lmol/L.
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harvesting the cells, and by centrifugation to remove
membrane fragments from the supernatant, whose ﬂuores-
cence was measured. The small residual ‘uptake’ found even
with incubation on ice may reﬂect contamination, or a minor
component of uptake because of passive mechanisms, but as
our main interest is in the NMDA-induced component of
uptake, which was totally eliminated by incubation on ice,
the assay is valid for our purposes. This assay is both
quantitative and highly sensitive, and will therefore be
valuable for further studies of this phenomenon.
The endocytosis involves two components with different
characteristics
The fact that dextran size strongly affected the NMDA-
induced component of cellular uptake, but not the constitu-
tive component, indicates that different forms of endocytosis
are involved in the two cases. Dextrans greater than about
10 kDa are taken up predominately by macropinocytosis,
and 150 kDa dextran is speciﬁc for macropinocytosis (Araki
et al. 1996). We found that 150-kDa FITC-dextran uptake
was limited to the constitutive component of endocytosis,
whereas 4.4-kDa FITC-dextran was in both, suggesting that
the constitutive component is largely due to macropinocy-
tosis, whereas the NMDA-induced component is of some
other type (micropinocytosis, clathrin mediated endocytosis,
etc.). The next step will be to determine which, using
inhibitors of different types of endocytosis. A similar
dependence on dextran size was found in chick embryo
amacrine cells, where KA-induced endocytosis occurred with
FD4, but not with 42 kDa FITC-dextran (Borsello et al.
2003a). The occurrence of excitotoxicity-related endocytosis
of HRP in both the amacrine cell study and the present one
may seem surprising in view of the relatively large molecular
weight of HRP (44 kDa), but HRP molecules are essentially
spherical and probably subject to much less steric hindrance
than dextran (Matsukawa et al. 1997).
The induced endocytosis is mediated by calcium entry
following the activation of NMDA receptors
The calcium chelator EGTA totally blocked NMDA-induced
FD4 endocytosis demonstrating its dependence on calcium
entry through NMDA receptors. Although other means of
membrane depolarization such as incubation in high potas-
sium or of excitotoxic stimuli such as GLU or KA can also
trigger this endocytosis, they do so less strongly, and most of
their effect appears to be due to the activation of NMDA-
receptors by released GLU, as it is inhibited by the NMDA
antagonist MK-801.
The NMDA-induced component occurs primarily in a
subpopulation of neurons, in which the FITC-dextran is
strikingly targeted to the nucleus
Microscopic counting indicates that approximately 15.4% of
the cells show a strong nuclear FITC labeling. The number of
FITC labeled neurons after 6 h of NMDA exposure is not
signiﬁcantly different from 1 h NMDA exposure, suggesting
that this phenomenon occurs early after NMDA administra-
tion and concerns only a subpopulation of neurons. Time-
lapse experiments also conﬁrm the early occurrence of the
phenomenon as it is detectable as soon as 30 min after
(c) 
(b) 
(a) 
Fig. 9 c-Jun N-terminal protein kinase (JNK)-inhibition selectively
eliminates the N-methyl D-aspartate (NMDA)-induced component of
endocytosis and the neuronal death, 2 lmol/L D-JNKI1 was applied
1 h before NMDA exposure. (a) Visualization by confocal microscopy
of labeling with 4.4-kDa fluorescein isothiocyanate (FITC)-dextran
(FD4, green) and propidium iodide (PI, red). Neurons pre-treated with
2 lmol/L D-JNKI1 show labeling patterns similar to those of the con-
trols (Fig. 5a). Scale bar = 50 lmol/L. (b) Quantification of FITC-
dextran uptake, showing that the NMDA-induced uptake is blocked by
D-JNKI1, n = 9 for all groups. *p < 10)4 with respect to each of the
other groups (t-test). (c) Lactate dehydrogenase (LDH) release, in the
same cultures, confirming the protection by D-JNKI1. #p < 10)5 with
respect to non-NMDA untreated group. *p < 10)7 with respect to
NMDA-exposed untreated group. Error bars represent SEM.
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NMDA exposure. As measured by cellular FITC uptake,
increasing the NMDA exposure triggers an enhancement of
internalization, because of further accumulation of FITC-
dextran in the same subpopulation of neurons. Identiﬁcation
of the highly endocytic subpopulation will be further
examined, but previous studies showed a heterogenic
response of intracellular Ca2+ to NMDA treatment in cortical
cultures (Centeno et al. 2007), that suggests the existence of
different neuronal subpopulations.
Neither component of endocytosis involves specific
binding of the ligand to a saturable receptor
Competition with an unlabeled dextran had no effect on
either component of FITC-dextran endocytosis. This sug-
gests that neither component involved speciﬁc binding of the
FITC-dextran to a saturable dextran receptor (such as the
mannose receptor, which is expressed in cortical neurons
(Burudi and Re´gnier-Vigouroux 2001) and can mediate the
endocytosis of FITC-dextran (Hackstein et al. 2002). This
does not rule out the possibility that the FITC part of the
FITC-dextran contained a speciﬁc ligand, and free FITC was
indeed internalized in both components of the endocytosis
(although it may not have been free at the moment of
endocytosis). However, the weight of evidence favors a non-
speciﬁc uptake mechanism, as HRP was also taken up in the
present study and in the previous amacrine cell study
(Borsello et al. 2003a); and in organotypic hippocampal
cultures HRP and microperoxidase were both taken up by
NMDA-induced endocytosis (Borsello et al. 2003c). More-
over, apart from the size limitation with large dextrans, we
have not found any molecule that is not taken up in
excitotoxicity-associated endocytosis. The lack of ligand
speciﬁcity argues against the need for a speciﬁc receptor.
Relation between the NMDA-induced endocytosis and
neuronal death
The minimal dose for the NMDA-induced component to be
detectable was about 30 lmol/L NMDA, which is close to
the threshold for excitotoxicity in these cultures (about
30 lmol/L NMDA, Fig. 1b). Nevertheless, enhanced endo-
cytosis could be detected using the ﬂuorescent assay at a
combination of dose and exposure time (30 lmol/L NMDA,
1 h exposure) that had not yet induced LDH release, and
even with the strongly excitotoxic dose of 100 lmol/L
NMDA, the neurons were intensely labeled with FITC
dextran at a time when they showed no sign of cell death
judged from PI staining. This is in harmony with previous
results in chick embryo amacrine cells (Borsello et al.
2003a). Nevertheless, the neurons with nuclear FITC-dextran
did ultimately die, as they were no longer present at 24 h of
NMDA. Tracking of these neurons using time-lapse micros-
copy revealed the cell death dynamics. The fact that
membrane disintegration was a rapid phenomenon accom-
panied by a total and rapid loss of intracellular ﬂuorescence
may explain why neurons were never stained with both
FITC-dextran and PI.
The fact that the endocytosis occurs before cell death does
not exclude its involvement in the death mechanism.
Enhanced endocytosis has been associated with several
cases of (non-excitotoxic) neuronal death (Clarke 1982;
Hornung et al. 1989), and neurodegeneration (Cataldo et al.
1997), but in other cases of cell death it does not occur
(Borsello et al. 2002), and in one case of apoptosis it was
shown to be decreased below normal constitutive levels
(Cosulich et al. 1997). In these cases the endocytosis was not
shown to be causally implicated in the cell death, but in two
studies of photoreceptor degeneration in mutant drosophila,
the death mechanism was shown to be blocked by a dynamin
mutation that blocked clathrin-dependent endocytosis (Allo-
way et al. 2000; Kiselev et al. 2000). And most relevant to
the present study, NMDA-induced death of cultured hippo-
campal neurons was prevented by broad spectrum inhibitors
of clathrin-mediated endocytosis or a speciﬁc inhibitor of
a-amino-3-hydroxy-5-methylisoxazole-4-propionate receptor
endocytosis (Wang et al. 2004).
The fact that excitotoxic treatment leads to enhanced
endocytosis before the onset of cell death suggests that it may
serve as a means for targeting drugs into excitotoxically
stressed neurons before they die. We are currently exploring
this, and have preliminary evidence that an equivalent
endocytic phenomenon occurs in a clinically relevant model
of cerebral ischemia (Vaslin et al. 2005).
Relevance of the present experimental model to the
excitotoxicity-associated endocytosis described in intact
tissues
If the present dissociated neuron model is to be used for
clarifying the mechanisms of endocytosis induced by
excitotoxic stimuli, it is important to be sure that the same
phenomenon is occurring in the present model as in the
previous studies in intact tissues: chick embryo amacrine
cells (Borsello et al. 2003a) and hippocampal organotypic
cultures (Borsello et al. 2003c). This criterion seems to be
met, because the present NMDA-induced endocytosis has
several striking points in common with the previous
phenomena: both occur in viable neurons, but require a
stimulus close to the excitotoxic threshold; both are inhibited
by the JNK cascade inhibitor D-JNKI1 (see below); both lack
ligand speciﬁcity; and both have a size limitation, occurring
only with small dextrans.
Dependence of the NMDA-induced component of
excitotoxicity on the JNK pathway
In many cases of excitotoxicity JNK is activated, and in the
present model this occurs after as little as 10 min of NMDA
treatment (Borsello et al. 2003b). Moreover, JNK inhibition
has been shown in several cases to protect against excito-
toxicity and cerebral ischemia (Borsello et al. 2003b;
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Bogoyevitch et al. 2004; Guan et al. 2005), and in the
present model, as the present experiments conﬁrm, total
protection is afforded by the retro-inverso peptide inhibitor
D-JNKI1 (Borsello et al. 2003b). JNK is also causally
implicated in several examples of endocytosis (Nakahara
et al. 2004; Pelkmans et al. 2005), including NMDA-
induced endocytosis (Borsello et al. 2003c). The relationship
between signaling pathways mediating excitotoxicity and
those mediating the associated endocytosis is largely
unknown, but D-JNKI1 is known to block the excitotoxic-
ity-induced activation of caspase-3 (Centeno et al. 2007),
and caspases are known to modify endocytosis, which they
can either increase (Sarin et al. 1998), or decrease (Cosulich
et al. 1997).
Conclusion
Endocytosis induced by an excitotoxic stimulus may be
important because of its possible implication in the mech-
anism of excitotoxicity, and because it provides a potential
means for targeting drugs into the stressed cells. In the
present paper, we show for the ﬁrst time that dissociated
cortical neuronal cultures reproduce the same phenomenon
as in intact preparations and can therefore be used for
analyzing it; we introduce a ﬂuorescent assay to facilitate its
quantitative analysis; and we characterize its basic properties,
setting the stage for an in depth analysis.
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